Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Wei, Cang"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Cervical cancer is one of the three major female gynecological malignancies, becoming a major global health challenge. Although about 90% of early-stage patients can be cured by surgery, advanced-stage patients still need new treatment methods to imp
Externí odkaz:
https://doaj.org/article/c035a908217047d498c1f3337749c996
Autor:
Xiaoyu Wang, Wei Cang, Xiaomei Liu, Yu Cheng, Xirun Wan, Fengzhi Feng, Tong Ren, Jun Zhao, Fang Jiang, Hongyan Cheng, Yu Gu, Lihua Chen, Chen Li, Xiuqin Li, Junjun Yang, Xin Lu, Yang Xiang
Publikováno v:
EClinicalMedicine, Vol 59, Iss , Pp 101974- (2023)
Summary: Background: Synergistic antitumor effects of immunotherapy and chemotherapy have been demonstrated in several solid tumors. However, this combination strategy has not been addressed in gestational trophoblastic neoplasia (GTN) cases. We ther
Externí odkaz:
https://doaj.org/article/1068d68eb7ad463a80875bfff149b0b4
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveTo compare the oncological outcomes of radical surgery and radical radiotherapy in elderly (over 65 years) patients with early-stage cervical cancer (IB-IIA).MethodsElderly patients with stage IB-IIA cervical cancer treated at Peking Union M
Externí odkaz:
https://doaj.org/article/074730b0dab2454c90e3ace84a92d64e
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveTo evaluate the oncological and reproductive outcomes in patients with advanced-stage ovarian immature teratoma (IMT).MethodsWe retrospectively reviewed the medical records of patients with advanced-stage IMT who were treated with surgery be
Externí odkaz:
https://doaj.org/article/cb5b5e5ffa514982be529cb2f5b2a1cc
Publikováno v:
In Journal of Retailing and Consumer Services May 2020 54
Publikováno v:
Biomedicines, Vol 11, Iss 3, p 868 (2023)
The effect of cervical cancer immunotherapy is limited. Combination therapy will be a new direction for cervical cancer. Thus, it is essential to discover a novel and available predictive biomarker to stratify patients who may benefit from immunother
Externí odkaz:
https://doaj.org/article/bb0872b754d440358676870afe649c17
Autor:
An-Yue Wu, Li-Ying Gu, Wei Cang, Meng-Xing Cheng, Wen-Jing Wang, Wen Di, Lei Huang, Li-Hua Qiu
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-14 (2019)
Abstract Background High-grade serous ovarian cancer (HGSOC) is the most lethal of all gynecological malignancies. Patients often suffer from chemoresistance. Several studies have reported that Fn14 could regulate migration, invasion, and angiogenesi
Externí odkaz:
https://doaj.org/article/0df58c9a1cb1428a82ad170094149f05
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 102:782-790
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f3b121c4673c7824c7625befb6cb8f7
https://doi.org/10.1111/aogs.14558
https://doi.org/10.1111/aogs.14558
Publikováno v:
In Chinese Herbal Medicines October 2018 10(4):437-444
Autor:
Hongyan Cheng, Yujia Kong, Xirun Wan, Yang Xiang, Xiaoyu Wang, Jun Zhao, Junjun Yang, Wei Cang, Liju Zong, Yu Gu
Publikováno v:
The Lancet Oncology. 22:1609-1617
Summary Background Treatment options for patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia are scarce. The synergistic antitumour effect of immunotherapy and antiangiogenic drugs has been shown in many solid tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bd28114300dab6b5d36823c907bf18d
https://doi.org/10.1016/s1470-2045(21)00460-5
https://doi.org/10.1016/s1470-2045(21)00460-5